ALNY logo

Alnylam Pharmaceuticals (ALNY) Depreciation and amortization

annual D&A:

$56.67M+$2.62M(+4.84%)
December 31, 2024

Summary

  • As of today (June 2, 2025), ALNY annual depreciation & amortization is $56.67 million, with the most recent change of +$2.62 million (+4.84%) on December 31, 2024.
  • During the last 3 years, ALNY annual D&A has fallen by -$33.02 million (-36.82%).
  • ALNY annual D&A is now -36.82% below its all-time high of $89.69 million, reached on December 31, 2021.

Performance

ALNY Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYincome statement metrics

quarterly D&A:

$14.40M+$34.95M(+170.11%)
March 31, 2025

Summary

  • As of today (June 2, 2025), ALNY quarterly depreciation & amortization is $14.40 million, with the most recent change of +$34.95 million (+170.11%) on March 31, 2025.
  • Over the past year, ALNY quarterly D&A has increased by +$888.00 thousand (+6.57%).
  • ALNY quarterly D&A is now -60.71% below its all-time high of $36.66 million, reached on June 30, 2024.

Performance

ALNY quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYincome statement metrics

TTM D&A:

$57.56M+$888.00K(+1.57%)
March 31, 2025

Summary

  • As of today (June 2, 2025), ALNY TTM depreciation & amortization is $57.56 million, with the most recent change of +$888.00 thousand (+1.57%) on March 31, 2025.
  • Over the past year, ALNY TTM D&A has increased by +$16.07 million (+38.72%).
  • ALNY TTM D&A is now -40.58% below its all-time high of $96.87 million, reached on March 31, 2022.

Performance

ALNY TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYincome statement metrics

ALNY Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.8%+6.6%+38.7%
3 y3 years-36.8%-27.2%-40.6%
5 y5 years+4.2%-15.3%+0.5%

ALNY Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-36.8%+27.4%-60.7%+170.1%-40.6%+38.7%
5 y5-year-36.8%+27.4%-60.7%+170.1%-40.6%+38.7%
alltimeall time-36.8%>+9999.0%-60.7%+170.1%-40.6%>+9999.0%

ALNY Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$14.40M(-170.1%)
$57.56M(+1.6%)
Dec 2024
$56.67M(+4.8%)
-$20.55M(-176.0%)
$56.67M(-2.6%)
Sep 2024
-
$27.04M(-26.2%)
$58.21M(+6.4%)
Jun 2024
-
$36.66M(+171.2%)
$54.71M(+31.8%)
Mar 2024
-
$13.52M(-171.1%)
$41.49M(-23.2%)
Dec 2023
$54.05M(+21.6%)
-$19.00M(-180.8%)
$54.05M(-4.9%)
Sep 2023
-
$23.53M(+0.4%)
$56.86M(+5.3%)
Jun 2023
-
$23.45M(-10.1%)
$53.98M(+6.3%)
Mar 2023
-
$26.08M(-261.0%)
$50.77M(+14.2%)
Dec 2022
$44.47M(-50.4%)
-$16.20M(-178.4%)
$44.47M(-45.8%)
Sep 2022
-
$20.65M(+2.0%)
$82.12M(-3.0%)
Jun 2022
-
$20.24M(+2.3%)
$84.69M(-12.6%)
Mar 2022
-
$19.78M(-7.8%)
$96.87M(+8.0%)
Dec 2021
$89.69M(+20.5%)
$21.45M(-7.6%)
$89.69M(+0.6%)
Sep 2021
-
$23.22M(-28.4%)
$89.12M(+5.3%)
Jun 2021
-
$32.42M(+157.3%)
$84.67M(+20.9%)
Mar 2021
-
$12.60M(-39.7%)
$70.03M(-5.9%)
Dec 2020
$74.44M(+36.9%)
$20.88M(+11.2%)
$74.44M(+9.0%)
Sep 2020
-
$18.77M(+5.6%)
$68.32M(+8.7%)
Jun 2020
-
$17.78M(+4.5%)
$62.87M(+9.8%)
Mar 2020
-
$17.01M(+15.2%)
$57.28M(+5.4%)
Dec 2019
$54.37M(+256.6%)
$14.76M(+10.8%)
$54.37M(+10.9%)
Sep 2019
-
$13.33M(+9.4%)
$49.03M(+35.8%)
Jun 2019
-
$12.19M(-13.5%)
$36.11M(+38.0%)
Mar 2019
-
$14.09M(+49.5%)
$26.16M(+71.6%)
Dec 2018
$15.25M(+28.2%)
$9.43M(+2227.4%)
$15.25M(+89.0%)
Sep 2018
-
$405.00K(-81.9%)
$8.07M(-28.3%)
Jun 2018
-
$2.24M(-29.5%)
$11.25M(-6.8%)
Mar 2018
-
$3.18M(+41.6%)
$12.08M(+1.5%)
Dec 2017
$11.90M(-21.4%)
$2.25M(-37.4%)
$11.90M(-6.1%)
Sep 2017
-
$3.59M(+17.0%)
$12.67M(+0.7%)
Jun 2017
-
$3.07M(+2.2%)
$12.58M(-7.0%)
Mar 2017
-
$3.00M(-0.6%)
$13.53M(-10.6%)
Dec 2016
$15.13M(-20.6%)
$3.02M(-13.8%)
$15.13M(-11.9%)
Sep 2016
-
$3.50M(-12.7%)
$17.18M(-9.3%)
Jun 2016
-
$4.01M(-12.8%)
$18.95M(-5.1%)
Mar 2016
-
$4.60M(-9.2%)
$19.96M(+4.8%)
Dec 2015
$19.05M(+59.7%)
$5.07M(-3.8%)
$19.05M(+10.0%)
Sep 2015
-
$5.27M(+5.0%)
$17.32M(+14.2%)
Jun 2015
-
$5.02M(+36.1%)
$15.17M(+16.5%)
Mar 2015
-
$3.69M(+10.4%)
$13.02M(+9.1%)
Dec 2014
$11.93M
$3.34M(+7.2%)
$11.93M(+6.4%)
Sep 2014
-
$3.12M(+8.7%)
$11.21M(+3.3%)
DateAnnualQuarterlyTTM
Jun 2014
-
$2.87M(+10.3%)
$10.86M(+1.5%)
Mar 2014
-
$2.60M(-1.0%)
$10.70M(+4.6%)
Dec 2013
$10.23M(+13.2%)
$2.63M(-5.0%)
$10.23M(+6.3%)
Sep 2013
-
$2.76M(+2.0%)
$9.63M(+5.2%)
Jun 2013
-
$2.71M(+27.5%)
$9.15M(+1.2%)
Mar 2013
-
$2.13M(+5.1%)
$9.04M(+0.1%)
Dec 2012
$9.04M(+76.3%)
$2.02M(-11.4%)
$9.04M(+9.5%)
Sep 2012
-
$2.29M(-12.3%)
$8.25M(+14.2%)
Jun 2012
-
$2.60M(+22.8%)
$7.22M(+22.3%)
Mar 2012
-
$2.12M(+71.5%)
$5.91M(+15.3%)
Dec 2011
$5.13M(+3.7%)
$1.24M(-2.0%)
$5.13M(-1.0%)
Sep 2011
-
$1.26M(-1.9%)
$5.18M(-0.1%)
Jun 2011
-
$1.29M(-3.9%)
$5.18M(+1.3%)
Mar 2011
-
$1.34M(+3.7%)
$5.12M(+3.6%)
Dec 2010
$4.94M(-17.5%)
$1.29M(+2.0%)
$4.94M(+3.2%)
Sep 2010
-
$1.27M(+3.5%)
$4.79M(+3.3%)
Jun 2010
-
$1.22M(+5.3%)
$4.63M(-13.5%)
Mar 2010
-
$1.16M(+2.2%)
$5.35M(-10.7%)
Dec 2009
$5.99M(+4.6%)
$1.14M(+2.3%)
$5.99M(-9.9%)
Sep 2009
-
$1.11M(-42.8%)
$6.65M(-7.2%)
Jun 2009
-
$1.94M(+7.8%)
$7.17M(+9.1%)
Mar 2009
-
$1.80M(+0.2%)
$6.58M(+14.9%)
Dec 2008
$5.73M(+40.3%)
$1.80M(+10.2%)
$5.73M(+18.6%)
Sep 2008
-
$1.63M(+21.2%)
$4.83M(+13.7%)
Jun 2008
-
$1.35M(+41.5%)
$4.25M(+10.7%)
Mar 2008
-
$951.00K(+5.4%)
$3.84M(-6.0%)
Dec 2007
$4.08M(+7.0%)
$902.00K(-13.9%)
$4.08M(-4.3%)
Sep 2007
-
$1.05M(+11.8%)
$4.27M(-15.8%)
Jun 2007
-
$937.00K(-21.6%)
$5.07M(+20.1%)
Mar 2007
-
$1.20M(+9.9%)
$4.22M(+10.6%)
Dec 2006
$3.81M(+22.3%)
$1.09M(-41.3%)
$3.81M(+9.6%)
Sep 2006
-
$1.85M(+2003.4%)
$3.48M(+46.9%)
Jun 2006
-
$88.00K(-88.8%)
$2.37M(-26.7%)
Mar 2006
-
$789.00K(+4.9%)
$3.23M(+3.7%)
Dec 2005
$3.12M(+27.6%)
$752.00K(+1.6%)
$3.12M(+0.0%)
Sep 2005
-
$740.00K(-22.3%)
$3.12M(+0.4%)
Jun 2005
-
$952.00K(+41.0%)
$3.11M(+19.1%)
Mar 2005
-
$675.00K(-10.1%)
$2.61M(+6.7%)
Dec 2004
$2.44M(+191.6%)
$751.00K(+3.2%)
$2.44M(+44.4%)
Sep 2004
-
$728.00K(+60.4%)
$1.69M(+75.4%)
Jun 2004
-
$454.00K(-11.2%)
$965.00K(+88.8%)
Mar 2004
-
$511.00K
$511.00K
Dec 2003
$838.00K(+2227.8%)
-
-
Dec 2002
$36.00K
-
-

FAQ

  • What is Alnylam Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals annual D&A year-on-year change?
  • What is Alnylam Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals quarterly D&A year-on-year change?
  • What is Alnylam Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals TTM D&A year-on-year change?

What is Alnylam Pharmaceuticals annual depreciation & amortization?

The current annual D&A of ALNY is $56.67M

What is the all time high annual D&A for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high annual depreciation & amortization is $89.69M

What is Alnylam Pharmaceuticals annual D&A year-on-year change?

Over the past year, ALNY annual depreciation & amortization has changed by +$2.62M (+4.84%)

What is Alnylam Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of ALNY is $14.40M

What is the all time high quarterly D&A for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high quarterly depreciation & amortization is $36.66M

What is Alnylam Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, ALNY quarterly depreciation & amortization has changed by +$888.00K (+6.57%)

What is Alnylam Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of ALNY is $57.56M

What is the all time high TTM D&A for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high TTM depreciation & amortization is $96.87M

What is Alnylam Pharmaceuticals TTM D&A year-on-year change?

Over the past year, ALNY TTM depreciation & amortization has changed by +$16.07M (+38.72%)
On this page